NEW YORK (GenomeWeb) – Veracyte, Rosetta Genomics, and NanoString Technologies led a lineup of firms in the GenomeWeb Daily News Index that saw their share prices retreat in April, as the Index took a 5 percent hit during the month.

Overall, stocks for 22 of the 29 companies in the Index dropped in April with Veracyte (-25 percent), Rosetta Genomics (-24 percent), and NanoString (-21 percent) pacing the decliners. The gainers were led by Myriad Genetics (+23 percent) and Sequenom (+11 percent) as the only two firms with double-digit percentage increases in April.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.